Financials data is unavailable for this security.
View more
Year on year Embla Medical hf grew revenues 9.33% from 718.65m to 785.68m. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 37.34% net income growth from 42.51m to 58.39m.
| Gross margin | 62.02% |
|---|---|
| Net profit margin | 8.25% |
| Operating margin | 12.60% |
| Return on assets | 4.75% |
|---|---|
| Return on equity | 9.47% |
| Return on investment | 5.51% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Embla Medical hf fell by 3.98m. However, the company earned 94.32m from its operations for a Cash Flow Margin of 12.01%. In addition the company used 57.15m on investing activities and also paid 40.96m in financing cash flows.
| Cash flow per share | 2.04 |
|---|---|
| Price/Cash flow per share | 17.76 |
| Book value per share | 13.06 |
|---|---|
| Tangible book value per share | -2.08 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.99 |
|---|---|
| Quick ratio | 1.26 |
| Total debt/total equity | 0.69 |
|---|---|
| Total debt/total capital | 0.4074 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 36.53%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.07% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 0.00% |
| EPS growth(5 years) | -5.77 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 30.03 |
More ▼
